Summary
For Year 2026-27, Rossari Biotech reports the following shareholding: Total Promoters at 68.15%, Mutual Fund at 13.38%, Insurance at 4.01%, Foreign Institutional Investors at 2.18%, Domestic Institutional Investors at 0.81%, and Retail at 11.46%. This breakdown provides a quick snapshot of ownership distribution for Rossari Biotech in 2026-27.
Rossari Biotech FAQs
As of 05-2026, the promoter shareholding in Rossari Biotech stands at 68.15% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Rossari Biotech is 2.18% and 0.81% respectively.
The retail shareholding of the Rossari Biotech is 11.46%.
Changes in shareholding patterns of Rossari Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Rossari Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
